Quantitative ultrasonic integrated backscatter of the intima-media complex, serum level of matrix metalloprotease-9 and simvastatin in hyperlipemia patients

Journal of Central South University (Medical Sciences)

Volumn 33, Issue 2, 2008, Pages 160-164

  Zhang, Sai Dan ^a   Yang, Liu ^a   Yu, Guo Long ^a   Sun, Ming ^a   Zhou, Hong Yan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atherosclerosis; Carotid arteries; Hyperlipemia; Integrated backscatter; Matrix metalloprotease 9

Indexed keywords

GELATINASE B; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

ADULT; ARTICLE; BLOOD; CAROTID ARTERY; DRUG EFFECT; ECHOGRAPHY; FEMALE; HUMAN; HYPERLIPIDEMIA; INTIMA; MALE; MIDDLE AGED; TUNICA MEDIA;

ADULT; ANTICHOLESTEREMIC AGENTS; CAROTID ARTERIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; SIMVASTATIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 41049112925     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mulvany M J. Vascular remodeling in hypertension [J]. Eur Heart J, 1993, 14 (suppl C): 2-4.
2. Perez J E, Miller J G, Wickline S A, et al. Quantitative ultrasonic imaging: tissue characterization and instantaneous quantification of cardiac function [J]. J Am Coll Cardiol, 1992, 69 (20): 104-111.
3. Takiuchi S, Rakugi H, Honda K. Atherosclerotic alteration in human carotid arteries quantitative ultrasonic tissue characterization can identify high-risk [J]. Circulation, 2000, 10 (2): 766-770.
4. Paoli G, Mantovani P, Ardissino D. Pathogenesis of acute coronary syndromes: the activated plaque [J]. Ital Heart J, 2005, 6 (Suppl 3): 5-11.
5. Kawasak I M, Takatsu H, Noda T, et al. Noninvasive quantitative tissue characterization and two - dimensional color - coded map of human atherosclerotic lesions using ultrasound integrated back scatter: comparison between histology and integrated backscatter images [J]. Am J Coll Cardiol, 2001, 38 (2): 486-492.
6. ZHANG Mei, ZHANG Yun, ZHANG Yuan-yuan, et al. Effects of 4 drugs on endothelium function of atherosclerosis in rabbit model[J]. Chin J Circ, 2003, 18 (5): 379-381.
7. Kalela A, Koivu T A, Hoyhtya M, et al. Association of serum MMP-9 with autoantibodies against oxidized LDL [J]. Atherosclerosis, 2002, 160 (5): 161-165.
8. Feldman L J, Mazighi M, Scheuble A, et al. Differential expression of matrix metallo - proteinases after stent implantation and balloon angioplasty in the hypercholestero - lemic rabbit [J]. Circulation, 2001, 103 (3): 3117-3125.
9. Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metal loproteases-2 and -9 are elevated in patients with acute coronary syndromes [J]. J Am Coll Cardiol, 1998, 32 (2): 368-372.
10. Fatema K, Hirono O, Masakane I, et al. Dynamic assessment of myocardial involvement in patients with end-stage renal disease by ultrasonic tissue characterization and serum markers of collagen metabolism [J]. Clin Cardiol, 2004, 27 (4): 228-234.
11. LÜ Yi-jie, YAN Shu-hong, GUO Tao, et al. Effect of simvastatin on serum matrix metalloproteinases-1, matrix metalloproteinases-9, tissue inhibitor of metalloproteinases-1, high sensitive C-reactive protein levels in patients of acute coronary syndrome in serum normocholesterolemia and hypereholesterolemia level [J]. Chin J Cadiol, 2004, 32 (2): 109-113.
12. Yoko M D, Masanori M D, Haruko Y K, et al. Different effects of pravastatin and cerivastatin on the media of the carotid arteries as assessed by integrated backscatter ultrasound [J]. Circ J, 2004, 6 (8): 784-790.